Use of IGHV3-21 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post-germinal center leukemogenic selection (Q36658038)
Jump to navigation
Jump to search
scientific article published on 7 March 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Use of IGHV3-21 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post-germinal center leukemogenic selection |
scientific article published on 7 March 2008 |
Statements
1 reference
Use of IGHV3-21 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post-germinal center leukemogenic selection (English)
1 reference
William G Wierda
1 reference
Michael J Keating
1 reference
John C Byrd
1 reference
Neil E Kay
1 reference
Laura Z Rassenti
1 reference
John G Gribben
1 reference
Kanti R Rai
1 reference
George F Widhopf
1 reference
Emanuela M Ghia
1 reference
Sonia Jain
1 reference
Jennifer R Brown
1 reference
Andrew W Greaves
1 reference
Thomas J Kipps
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference